Results from the largest most comprehensive study to date evaluating SIRT in liver metastases from colorectal cancer were presented at ASCO in 2012, ASCO-GI 2013 and ASCO in 2014. The various subsets of the MORE study, led by Andrew S. Kennedy M.D. Physician in Chief, Radiation Oncology Sarah Cannon Research Institute Nashville Tenn., have demonstrated safety and efficacy as well as the same in treating the elderly. The most recent set of data presented at ASCO in 2014 documented the ability to predict success of SIRT using standard laboratory tests prior to treatment.